Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation
Milica M. Borovcanin, Ivica Petrovic · 2026
Read Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation by Milica M. Borovcanin, Ivica Petrovic (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275439.txt.
Description
Milica M Borovcanin and Ivica Petrovic present a 2026 review article on GLP-1 medicines and suicide risk. These drugs first treated type 2 diabetes and now serve wider roles in obesity and metabolic care. The authors ask whether effects on inflammation and mental health could cut either way for patients.
The article reviews how diabetes and mental disorders overlap in clinics and in daily practice. It weighs reported benefits of GLP-1 drugs against signals that mood and suicidal thinking need watching. Inflammation sits at the centre of their argument, since it may link body metabolism with brain function. They urge combined, whole-patient care rather than prescribing focused on weight or blood sugar alone.
Catalog record
| CREATOR | Milica M. Borovcanin, Ivica Petrovic |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |